IRIS
SANTORO, Domenico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 21.935
NA - Nord America 18.829
AS - Asia 10.792
SA - Sud America 4.155
Continente sconosciuto - Info sul continente non disponibili 815
AF - Africa 311
OC - Oceania 22
Totale 56.859
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.317
RU - Federazione Russa 10.242
SG - Singapore 4.438
BR - Brasile 3.510
IT - Italia 3.459
CN - Cina 2.884
IE - Irlanda 2.299
SE - Svezia 1.929
HK - Hong Kong 1.103
DE - Germania 922
VN - Vietnam 730
FR - Francia 669
UA - Ucraina 512
FI - Finlandia 471
NL - Olanda 411
IN - India 400
GB - Regno Unito 361
BD - Bangladesh 295
AR - Argentina 236
CA - Canada 233
PL - Polonia 203
MX - Messico 137
TR - Turchia 121
EC - Ecuador 104
IQ - Iraq 102
JP - Giappone 95
ZA - Sudafrica 91
ID - Indonesia 87
CO - Colombia 79
ES - Italia 76
AT - Austria 68
VE - Venezuela 66
PK - Pakistan 65
UZ - Uzbekistan 65
BE - Belgio 61
MA - Marocco 52
CL - Cile 44
CZ - Repubblica Ceca 44
PY - Paraguay 41
AE - Emirati Arabi Uniti 33
JM - Giamaica 32
PE - Perù 32
AZ - Azerbaigian 31
MY - Malesia 31
KE - Kenya 30
NP - Nepal 30
PH - Filippine 29
SA - Arabia Saudita 29
IL - Israele 28
RO - Romania 28
EG - Egitto 26
CI - Costa d'Avorio 25
JO - Giordania 25
TN - Tunisia 25
UY - Uruguay 25
AL - Albania 22
CH - Svizzera 22
CR - Costa Rica 22
DZ - Algeria 22
GR - Grecia 21
LT - Lituania 20
KZ - Kazakistan 19
DO - Repubblica Dominicana 18
KG - Kirghizistan 17
BO - Bolivia 16
IR - Iran 15
AU - Australia 14
GT - Guatemala 14
LB - Libano 14
BG - Bulgaria 12
GE - Georgia 11
HN - Honduras 11
OM - Oman 11
PS - Palestinian Territory 11
ET - Etiopia 10
EU - Europa 10
RS - Serbia 10
TT - Trinidad e Tobago 10
KR - Corea 9
LV - Lettonia 8
NO - Norvegia 8
PA - Panama 8
SY - Repubblica araba siriana 8
AM - Armenia 7
BY - Bielorussia 7
CY - Cipro 7
NI - Nicaragua 7
NZ - Nuova Zelanda 7
PT - Portogallo 7
SN - Senegal 7
SV - El Salvador 7
TH - Thailandia 7
BH - Bahrain 6
EE - Estonia 6
HU - Ungheria 6
MD - Moldavia 6
XK - ???statistics.table.value.countryCode.XK??? 6
BA - Bosnia-Erzegovina 5
BN - Brunei Darussalam 5
LK - Sri Lanka 5
Totale 55.982
Salva come PNG Salva come JPEG
Città #
Moscow 3.118
Ashburn 2.826
Dublin 2.293
Singapore 2.232
Dallas 2.118
Chandler 1.581
Jacksonville 1.102
Hong Kong 1.094
Beijing 1.009
Nyköping 959
San Jose 844
Council Bluffs 642
The Dalles 566
Princeton 425
Los Angeles 415
Medford 392
Lauterbourg 387
Messina 380
Cambridge 359
Dearborn 354
Des Moines 323
New York 292
São Paulo 291
Oude Meer 280
Boardman 254
Ann Arbor 243
Ho Chi Minh City 228
Buffalo 222
Munich 219
Rome 213
Milan 194
Warsaw 178
Hanoi 163
Hyderabad 149
Santa Clara 140
Tianjin 133
San Mateo 121
Frankfurt am Main 114
Redondo Beach 114
Rio de Janeiro 106
Woodbridge 103
Jinan 102
Belo Horizonte 101
Guangzhou 100
Houston 98
Wilmington 94
Orem 92
Tokyo 82
Turku 75
Bremen 73
Brooklyn 73
Seattle 66
Shenyang 66
Catania 64
Montreal 64
Palermo 63
Brasília 62
Denver 61
Shanghai 58
Tashkent 58
Brussels 56
Nanjing 56
Nuremberg 56
Curitiba 55
Columbus 53
Chennai 52
Pune 52
Johannesburg 49
Stockholm 48
Ottawa 47
Phoenix 47
Turin 47
Porto Alegre 46
Helsinki 44
Mexico City 44
Campinas 43
Chicago 43
Atlanta 42
Florence 41
Hebei 41
London 41
Baghdad 40
Vienna 40
Naples 39
Bologna 38
Genova 38
Amsterdam 37
Lancaster 36
Poplar 36
Guayaquil 35
Hangzhou 34
Manchester 34
Boston 33
Shenzhen 33
Zhengzhou 33
Düsseldorf 32
Jakarta 32
Ningbo 32
Norwalk 32
Quito 32
Totale 30.297
Salva come PNG Salva come JPEG
Nome #
La sindrome MIA ( malnutrizione-infiammazione-aterosclerosi nel paziente uremico 1.537
Amiloidosi renale e fibrosi cistica: Ruolo della terapia con colchicina 780
Terapia nutrizionale nell'IRC in fase conservativa: suggerimenti di pratica clinica e di applicazione delle linee guida 535
Henoch-Schonlein purpura associated with acetaminophen and codeine. 392
Impotence in the XVIII century as described by Gian Pietro Fusanacci and Tommaso Eduardo Beatty 294
Urine therapy through the centuries. 291
Circulating sclerostin and Dickkopf-1 correlate with vascular calcifications in non-dialysis chronic kidney disease 267
[Long-term outcome of renal function in women with preeclampia and pregestational diabetes] 258
[Periorbital purpura: a pathognomonic but late sign of AL amyloidosis] / Porpora periorbitaria: un segnale patognomonico ma tardivo di amiloidosi AL 244
[Management of hyperphosphatemia in patients with chronic kidney disease] 237
[Lupus Nephritis and Enteritis, a dual simultaneous involvement with Arteriolar Thrombosis] 235
[Complement factor B mutation in atypical hemolytic uremic syndrome. Rare cause of rare disease] 232
Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study 231
[From hyponatremia to tolvaptan] 230
Association of higher advanced oxidation protein  products (AOPPs) levels in patients with diabetic  and hypertensive nephropathy 227
Metformin-related lactic acidosis: is it a myth or an underestimated reality? 226
[Renal and extra-renal involvement in sclerodermia.] 225
A new approach to the evaluation of hyperphosphatemia in chronic kidney disease 223
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens 220
Therapy of Hyperhomocysteinemia in Hemodialysis Patients: Effects of Folates and N-Acetylcysteine 216
Association of VDR gene polymorphisms with heart disease in chronic kidney disease patients 215
[Long-term outcome of renal function in women with preeclampia and pregestational diabetes] 211
ACCIDENTAL DISCOVERY OF LUNG METATSTASES FROM DIFFERENTIATED THYROID CANCER BY TC-99M PERTECHNETATE SCAN IN A PATIENT WITH SECONDARY HYPERPARATHYROIDISM 209
Flavocoxid, a Natural Antioxidant, Protects Mouse Kidney from Cadmium-Induced Toxicity. 209
Sclerostin levels in uremic patients: a link between bone and vascular disease 203
Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure 201
Auxin induces cell proliferation in an experimental model of mammalian renal tubular epithelial cells 201
Defense mechanisms in hemodialysis-dependent patients 198
Role of Paricalcitol in Modulating the Immune Response in Patients with Renal Disease 198
Association of parathyroid carcinoma and thyroid disorders: A clinical review 194
Sevalamer Hydrochloride, Sevelamer Carbonate and Lanthanum Carbonate: In Vitro and In Vivo Effects on Gastric Environment 193
History of L-carnitine: Implications for renal disease 191
Antiosteoporotic activity of genistein aglycone in postmenopausal women: Evidence from a post-hoc analysis of a multicenter randomized controlled trial 191
Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study 191
The Myth of Water and Salt: From Aquaretics to Tenapanor 190
Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease 188
An update on calcium metabolism alterations and cardiovascular risk in patients with chronic kidney disease: questions, myths and facts. 188
Adaptation of the Mishel Uncertainty of Illness Scale (MUIS) for chronic patients in Italy 186
In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: A population-based study 186
Accidental discovery of lung metastases from differentiated thyroid cancer by 99mTc sodium pertechnetate scan in a patient with secondary hyperparathyroidism 185
C3 glomerulopathy in cystic fibrosis: a casereport 185
Delayed graft function and chronic allograft nephropathy: Diagnostic and prognostic role of neutrophil gelatinase-associated lipocalin 184
ACCUMULO DI TECNEZIO IN METASTASI POLMONARI DA CARCINOMA DIFFERENZIATO TIROIDEO (CDT): UNA RARA EVENIENZA 182
Acetate-free biofiltration to remove fibroblast growth factor 23 in hemodialysis patients: a pilot study 182
Correction to: Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 182
Chronic Kidney Disease Management in General Practice: A Focus on Inappropriate Drugs Prescriptions 180
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy 179
ALTERAZIONI RENALI IN UN CASO DI CRIOGLOBULINEMIA MISTA DI TIPO 2 IN UN PAZIENTE AFFETTO DA LINFOMA CON CELLULE B. 179
Endothelial dysfunction in chronic renal failure. 178
Beneficial effects of oral pure caffeine on oxidative stress 178
Hypernatraemia and low eGFR at hospitalization in COVID-19 patients: a deadly combination 178
Kidney disease and psoriasis: novel evidences beyond old concepts 177
Autoimmune thyroiditis and glomerulopathies 176
Absorbable phosphate in medication 175
The concept of the urine test and specific reaction of the urine in various diseases according to Enrico Cauchi - member of the medical council of Malta (1933) 174
A Keynesian perspective on the health economics of kidney transplantation would strengthen the value of the whole organ donation and transplantation service 170
Impotence in the 18th and 19th century: concepts of etiology and approaches to therapy. 169
A prospective, multicenter, randomized, controlled study: the Correction of Metabolic Acidosis with Use of Bicarbonate in Chronic Renal Insufficiency (UBI) Study 169
Thyroid hormone autoantibodies: Are they a better marker to detect early thyroid damage in patients with hematologic cancers receiving tyrosine kinase inhibitor or immunoregulatory drug treatments? 169
Stress ossidativo in una popolazione di ipertesi e nefropatici: utilità del dosaggio dell’AOPP 169
A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy 168
Convective Dialysis Reduces Mortality Risk: Results From a Large Observational, Population-Based Analysis 168
Opposite actions of urotensin II and relaxin-2 on cellular expression of fibronectin in renal fibrosis: A preliminary experimental study 167
Case report on pathogenetic link between gluten and IgA nephropathy 167
Negative Emotions in End-Stage Renal Disease: Are Anxiety Symptoms Related to Levels of Circulating Catecholamines? 166
A longitudinal study of sleep disorders in early-stage chronic kidney disease 165
Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents? 165
Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis 164
Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease 162
Kidney biopsy in type 2 diabetic patients: Critical reflections on present indications and diagnostic alternatives 162
Renoprotective effect of erythropoietin in zebrafish after administration of gentamicin: an immunohistochemical study for β-catenin and c-kit expression 161
The Management of Diabetes Mellitus in Patients with Chronic Kidney Disease: A Population-Based Study in Southern Italy 161
[From scientific evidence to clinical recommendations: outlooks and challenges for the SIN (Italian Society of Nephrology)] 161
Vitamin D receptor polymorphism in chronic kidney disease patients with complicated cardiovascular disease 161
Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report 160
Autonomic dysfunction in uremia 159
Analisi dei costi dell’eritropoietina in dialisi nella regione sicilia 159
Vascular access for hemodialysis: current perspectives 159
Nephro-oncology: a link in evolution 158
Gender differences in new hypoglycemic drug effects on renal outcomes: a systematic review 158
Caso clinico di una bambina con lichen follicolare e sindrome nefrosica 157
Interplay of vitamin D, erythropoiesis, and the renin-angiotensin system 157
Cystic Fibrosis: A Risk Condition for Renal Disease 157
Copy number variant analysis and genome-wide association study identify loci with large effect for vesicoureteral reflux 157
EFFECTIVENESS OF L-CARNITINE THERAPY IN UREMIC ANEMIA 156
Choice of dialysis treatment and type of medical unit (private vs public): application of a recursive bivariate probit 156
Dense deposit disease in a child with febrile sore throat 156
[Nutritional diet therapy in the management of the patient with Chronic Kidney Disease in advanced phase to delay the beginning and reduce the frequency of dialysis. An option also in the pre-emptive transplant program] 156
Indole-3-acetic acid correlates with monocyte-to-high-density lipoprotein (HDL) ratio (MHR) in chronic kidney disease patients 156
Pain in Renal Disease. 155
Semaphorin 3A serum levels are influenced by haemodialysis: what clinical significance? 155
Dual αvβ3 and αvβ5 blockade attenuates fibrotic and vascular alterations in a murine model of systemic sclerosis 155
Socio-economic factors, food habits and phosphorus levels in patients on hemodialysis 155
The aggressive diabetic kidney disease in youth-onset type 2 diabetes: Pathogenetic mechanisms and potential therapies 155
A Delphi consensus panel on nutritional therapy in chronic kidney disease 154
Salt-water imbalance and fluid overload in hemodialysis patients: a pivotal role of corin 153
SCLEROSTIN AND DICKKOPF-1 CORRELATE WITH VASCULAR CALCIFICATIONS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 153
Meccanismi di difesa in soggetti sottoposti a trattamento dialitico cronico 152
Correlation between Hyperkalemia and the Duration of Several Hospitalizations in Patients with Chronic Kidney Disease 151
Compliance ed emozioni in una popolazione di emodializzati 151
Totale 20.911
Salva come PNG Salva come JPEG
Categoria #
all - tutte 193.420
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 193.420
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.948 0 182 123 147 109 51 203 149 128 490 402 964
2022/20236.667 558 523 309 469 508 639 103 386 2.806 75 201 90
2023/20242.053 175 288 152 146 170 368 41 129 33 204 59 288
2024/20258.846 138 61 193 465 385 349 333 1.919 2.173 563 840 1.427
2025/202627.092 1.273 1.779 2.548 2.137 2.311 5.396 3.074 3.128 3.015 1.084 694 653
2026/20271.916 790 1.126 0 0 0 0 0 0 0 0 0 0
Totale 56.859